Biological Evaluation and Molecular Docking Study of Ferrociphenol as an Antimelanogenic Agent
Biochemistry Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bri/5240884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry Research International, online erschienen am 26.07.2026. Verfasst von Emna Ketata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biotechnology of Eukaryotes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia, fss.rnu.tn. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous hyperpigmentation disorders are associated with abnormal accumulation of melanin pigments, which can be treated using depigmenting agents. In the present study, we investigated the effect of ferrociphenol (Fc‐diOH), an organometallic intermediate used in the synthesis of hydroxy‐ferrocifen derivatives and previously reported as a tyrosinase inhibitor, on melanogenesis in B16F10 melanoma cells. Cell viability, melanin content, and tyrosinase activity assays demonstrated that treatment with Fc‐diOH significantly reduced intracellular melanin levels and tyrosinase activity by 32% and 25%, respectively, in B16F10 cells at 25 nM without inducing significant cytoxicity. Furthermore, the antimelanogenesis activity of Fc‐diOH was confirmed in vivo using zebrafish ( Danio rerio ) embryos. Fc‐diOH treatment at concentrations of 0.5 and 2 μM significantly inhibited melanin production and tyrosinase activity in zebrafish embryos without affecting embryonic development or viability. In addition, molecular docking analysis demonstrates that the p ‐hydroxyphenyl groups of Fc‐diOH make close contacts with the active site of a predicted human tyrosinase model, compared to arbutin and phenylthiourea. Taken together, these results strongly suggest that Fc‐diOH decreases tyrosinase activity and thereby negatively regulates melanogenesis in both B16F10 cells and zebrafish embryos. Therefore, Fc‐diOH represents a promising candidate as a depigmentation agent for the treatment of hyperpigmentation disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Biotechnology of Eukaryotes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia, fss.rnu.tn.
- Laboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia, fss.rnu.tn.
- Chimie ParisTech, PSL University, Paris, France.
- Institut Parisien de Chimie Moléculaire (IPCM), Sorbonne University, CNRS, Paris, France.
- Higher Institute of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia, fss.rnu.tn.
- Laboratory of Enzyme Engineering and Microbiology, National School of Engineering of Sfax, University of Sfax, Sfax, Tunisia, fss.rnu.tn.
ORCID-Profile: Emna Ketata
Zitieren
APA
Ketata, E., Baanannou, A., Ayadi, W., Pigeon, P., Neifar, A., Top, S., Masmoudi, S., Jaouen, G., El Arbi, M., & Gargouri, A. (2026). Biological Evaluation and Molecular Docking Study of Ferrociphenol as an Antimelanogenic Agent. Biochemistry Research International, 2026(1). https://doi.org/10.1155/bri/5240884
Vancouver
Ketata E, Baanannou A, Ayadi W, Pigeon P, Neifar A, Top S, et al. Biological Evaluation and Molecular Docking Study of Ferrociphenol as an Antimelanogenic Agent. Biochemistry Research International. 2026;2026(1). doi:10.1155/bri/5240884
BibTeX
@article{Ketata2026,
author = {Ketata, Emna and Baanannou, Aissette and Ayadi, Wajdi and Pigeon, Pascal and Neifar, Aref and Top, Siden and Masmoudi, Saber and Jaouen, Gérard and El Arbi, Mehdi and Gargouri, Ali},
title = {Biological Evaluation and Molecular Docking Study of Ferrociphenol as an Antimelanogenic Agent},
journal = {Biochemistry Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bri/5240884}
}
EUVIMED